Related Experiment Videos
Late coronary artery reperfusion: benefits and mechanisms
I A Alhaddad1, M Kazimuddin, E J Brown
1Bronx-Lebanon Hospital Center, Bronx, NY 10457, USA. alhaddad@pol.net
Insights
Late reperfusion therapy for acute myocardial infarction (AMI) can prevent adverse cardiac remodeling and arrhythmias, even without significant myocardial salvage. These benefits support reperfusion up to 24 hours post-symptom onset, particularly for large infarcts.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Acute myocardial infarction (AMI) traditionally considers reperfusion beyond 4-6 hours as having minimal impact on infarct size.
- However, emerging evidence suggests benefits even with late reperfusion, independent of significant myocardial salvage.
Purpose of the Study:
- To evaluate the benefits of late reperfusion therapy in acute myocardial infarction (AMI).
- To explore the mechanisms and clinical implications of reperfusion performed beyond the conventional time window.
Main Methods:
- Review of existing literature on late reperfusion strategies in AMI.
- Analysis of studies examining infarct expansion, left ventricular remodeling, and arrhythmogenicity post-reperfusion.
Main Results:
- Late reperfusion (up to 12 hours) significantly reduces mortality in AMI.
- Reperfusion between 13-24 hours, especially for large anterior AMIs, prevents infarct expansion and left ventricular remodeling.
- Late reperfusion contributes to electrical stability and reduces the risk of arrhythmias.
Conclusions:
- Late reperfusion therapy offers significant benefits in preventing adverse cardiac remodeling and reducing arrhythmia risk in AMI patients.
- Reperfusion up to 24 hours is justified in specific AMI cases, particularly large infarcts, to improve long-term outcomes and prevent heart failure.
Abstract:
In patients with acute myocardial infarction (AMI), coronary artery reperfusion beyond 4 to 6 h after the onset of symptoms is believed to have little or no effect on infarct size. However, benefits have been demonstrated even when reperfusion is performed late and without significant myocardial salvage. Late reperfusion prevents infarct expansion and left ventricular remodelling. The mechanism is multifactorial and partially related to salvage of small islets of still viable myocytes within the scar. Other benefits of late reperfusion are electrical stability and prevention of arrhythmias. The survival benefits of reperfusion are strongly dependent on the time after the onset of symptoms until treatment (better outcomes are obtained with earlier reperfusion). Based on the demonstration of a significant reduction in mortality, the current practice is to perform reperfusion up to 12 h after the onset of symptoms. The survival benefits of reperfusion performed 13 to 24 h after the onset of AMI are less certain; however, large AMIs, particularly anterior infarcts, have the maximum risk of remodelling. Thus, benefits of reperfusion on left ventricular remodelling, arrhythmogenicity and prevention of congestive heart failure justify reperfusion in this group of patients up to 24 h after the onset of symptoms.